Open Targets is a public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritization for approaches in oncology, neurodegeneration, and immunity and inflammation. The Open Targets Platform API offers data access. The public methods offer stable data to core set of data, data associations and evidence. The private methods offers target profile page and batch search, among other things. Paramenters include disease, datasource, datatype, file type (JSON, XML, CSV, TAB), scorevalues and more.